表纸
市场调查报告书
商品编码
1028862

抗体药物复合体 (ADC)的全球市场 (2021年) - COVID-19造成的成长和变化 (2030年)

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
  • 全貌
  • 简介
  • 目录
简介

本报告提供全球抗体药物复合体 (ADC) 市场相关调查分析,提供市场特征,市场规模与成长率,市场区隔,各地区·各国明细,竞争情形,市场占有率,趋势与策略相关的系统性资讯。

目录

第1章 摘要整理

第2章 抗体药物复合体 (ADC) 市场特征

第3章 抗体药物复合体 (ADC) 市场趋势与策略

第4章 抗体药物复合体 (ADC) 市场上COVID-19的影响

第5章 抗体药物复合体 (ADC)的市场规模与成长率

  • 全球抗体药物复合体 (ADC) 市场实际成果 (金额)
  • 全球抗体药物复合体 (ADC) 市场预测 (金额)

第6章 抗体药物复合体 (ADC) 市场区隔

  • 全球抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 单株抗体
  • 连接试剂
  • 药物/毒素
  • 其他
  • 全球抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 血液癌症
  • 乳癌
  • 卵巢癌症
  • 肺癌症
  • 脑瘤
  • 其他
  • 全球抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)
  • Adcertis
  • Kadcyla
  • 其他
  • 全球抗体药物复合体 (ADC) 市场:各技术,实际成果与预测 (金额)
  • 免疫原技术
  • Seattle Genetics技术
  • Immunomedics技术
  • 其他
  • 全球抗体药物复合体 (ADC) 市场:各终端用户,实际成果与预测 (金额)
  • 医院
  • 诊所
  • 其他

第7章 抗体药物复合体 (ADC) 市场各地区·各国分析

  • 全球抗体药物复合体 (ADC) 市场:各地区,实际成果与预测 (金额)
  • 全球抗体药物复合体 (ADC) 市场:各国,实际成果与预测 (金额)

第8章 亚太地区的抗体药物复合体 (ADC) 市场

  • 亚太地区的抗体药物复合体 (ADC) 市场概要
  • 地区资讯,COVID-19的影响,市场资讯,背景资讯,政府的积极推动,法规,法规机关,主要的协会,课税,公司税结构,投资,主要企业
  • 亚太地区的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 亚太地区的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 亚太地区的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第9章 中国的抗体药物复合体 (ADC) 市场

  • 中国的抗体药物复合体 (ADC) 市场概要
  • 中国的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 中国的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 中国的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第10章 印度的抗体药物复合体 (ADC) 市场

  • 印度的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 印度的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 印度的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第11章 日本的抗体药物复合体 (ADC) 市场

  • 日本的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 日本的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 日本的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第12章 澳洲的抗体药物复合体 (ADC) 市场

  • 澳洲的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 澳洲的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 澳洲的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第13章 印尼的抗体药物复合体 (ADC) 市场

  • 印尼的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 印尼的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 印尼的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第14章 韩国的抗体药物复合体 (ADC) 市场

  • 韩国的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 韩国的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 韩国的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第15章 西欧的抗体药物复合体 (ADC) 市场

  • 西欧的抗体药物复合体 (ADC) 市场概要
  • 西欧的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 西欧的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 西欧的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第16章 英国的抗体药物复合体 (ADC) 市场

  • 英国的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 英国的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 英国的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第17章 德国的抗体药物复合体 (ADC) 市场

  • 德国的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 德国的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 德国的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第18章 法国的抗体药物复合体 (ADC) 市场

  • 法国的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 法国的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 法国的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第19章 东欧的抗体药物复合体 (ADC) 市场

  • 东欧的抗体药物复合体 (ADC) 市场概要
  • 东欧的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 东欧的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 东欧的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第20章 俄罗斯的抗体药物复合体 (ADC) 市场

  • 俄罗斯的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 俄罗斯的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 俄罗斯的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第21章 北美的抗体药物复合体 (ADC) 市场

  • 北美的抗体药物复合体 (ADC) 市场概要
  • 北美的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 北美的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 北美的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第22章 美国的抗体药物复合体 (ADC) 市场

  • 美国的抗体药物复合体 (ADC) 市场概要
  • 美国的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 美国的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 美国的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第23章 南美的抗体药物复合体 (ADC) 市场

  • 南美的抗体药物复合体 (ADC) 市场概要
  • 南美的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 南美的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 南美的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第24章 巴西的抗体药物复合体 (ADC) 市场

  • 巴西的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 巴西的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 巴西的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第25章 中东的抗体药物复合体 (ADC) 市场

  • 中东的抗体药物复合体 (ADC) 市场概要
  • 中东的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 中东的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 中东的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第26章 非洲的抗体药物复合体 (ADC) 市场

  • 非洲的抗体药物复合体 (ADC) 市场概要
  • 非洲的抗体药物复合体 (ADC) 市场:各类型,实际成果与预测 (金额)
  • 非洲的抗体药物复合体 (ADC) 市场:各适应症,实际成果与预测 (金额)
  • 非洲的抗体药物复合体 (ADC) 市场:各产品,实际成果与预测 (金额)

第27章 抗体药物复合体 (ADC) 市场竞争情形和企业简介

  • 抗体药物复合体 (ADC) 市场竞争情形
  • 抗体药物复合体 (ADC) 市场企业简介
    • Bayer AG
    • Concortis Biotherapeutics
    • F. Hoffman-La Roche Ltd.
    • Immunomedics, Inc.
    • Oxford BioTherapeutics

第28章 抗体药物复合体 (ADC)的开发平台分析

第29章 抗体药物复合体 (ADC) 市场上主要的收购与合并

第30章 抗体药物复合体 (ADC) 市场未来发展预测与潜在的分析

第31章 附录

目录
Product Code: h886

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antibody drug conjugates market.

The report focuses on the antibody drug conjugates market which is experiencing strong growth. The report gives a guide to the antibody drug conjugates market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antibody drug conjugates? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antibody Drug Conjugates Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin; Others

2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Others

3) By Product: Adcertis; Kadcyla; Others

4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology; Others

5) By End User: Hospital; Clinics; Others

Companies Mentioned: Bayer AG; Concortis Biotherapeutics; F. Hoffman-La Roche Ltd.; Immunomedics; Oxford BioTherapeutics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Antibody Drug Conjugates Market Characteristics

3. Antibody Drug Conjugates Market Trends And Strategies

4. Impact Of COVID-19 On Antibody Drug Conjugates

5. Antibody Drug Conjugates Market Size And Growth

  • 5.1. Global Antibody Drug Conjugates Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Antibody Drug Conjugates Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Antibody Drug Conjugates Market Segmentation

  • 6.1. Global Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monoclonal Antibodies
  • Linker
  • Drug/Toxin
  • Others
  • 6.2. Global Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Blood Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Brain Tumor
  • Others
  • 6.3. Global Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Adcertis
  • Kadcyla
  • Others
  • 6.4. Global Antibody Drug Conjugates Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Immunogen Technology
  • Seattle Genetics Technology
  • Immunomedics Technology
  • Others
  • 6.5. Global Antibody Drug Conjugates Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital
  • Clinics
  • Others

7. Antibody Drug Conjugates Market Regional And Country Analysis

  • 7.1. Global Antibody Drug Conjugates Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Antibody Drug Conjugates Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Antibody Drug Conjugates Market

  • 8.1. Asia-Pacific Antibody Drug Conjugates Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.4. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Antibody Drug Conjugates Market

  • 9.1. China Antibody Drug Conjugates Market Overview
  • 9.2. China Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.4. China Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Antibody Drug Conjugates Market

  • 10.1. India Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.3. India Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Antibody Drug Conjugates Market

  • 11.1. Japan Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.3. Japan Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Antibody Drug Conjugates Market

  • 12.1. Australia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.3. Australia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Antibody Drug Conjugates Market

  • 13.1. Indonesia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.3. Indonesia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Antibody Drug Conjugates Market

  • 14.1. South Korea Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.3. South Korea Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Antibody Drug Conjugates Market

  • 15.1. Western Europe Antibody Drug Conjugates Market Overview
  • 15.2. Western Europe Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.4. Western Europe Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Antibody Drug Conjugates Market

  • 16.1. UK Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.3. UK Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Antibody Drug Conjugates Market

  • 17.1. Germany Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.3. Germany Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Antibody Drug Conjugates Market

  • 18.5. France Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.6. France Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.7. France Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Antibody Drug Conjugates Market

  • 19.1. Eastern Europe Antibody Drug Conjugates Market Overview
  • 19.2. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.4. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Antibody Drug Conjugates Market

  • 20.1. Russia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.3. Russia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Antibody Drug Conjugates Market

  • 21.1. North America Antibody Drug Conjugates Market Overview
  • 21.2. North America Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.4. North America Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Antibody Drug Conjugates Market

  • 22.1. USA Antibody Drug Conjugates Market Overview
  • 22.2. USA Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.4. USA Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Antibody Drug Conjugates Market

  • 23.1. South America Antibody Drug Conjugates Market Overview
  • 23.2. South America Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.4. South America Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Antibody Drug Conjugates Market

  • 24.1. Brazil Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.3. Brazil Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Antibody Drug Conjugates Market

  • 25.1. Middle East Antibody Drug Conjugates Market Overview
  • 25.2. Middle East Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.4. Middle East Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Antibody Drug Conjugates Market

  • 26.1. Africa Antibody Drug Conjugates Market Overview
  • 26.2. Africa Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.4. Africa Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Antibody Drug Conjugates Market Competitive Landscape And Company Profiles

  • 27.1. Antibody Drug Conjugates Market Competitive Landscape
  • 27.2. Antibody Drug Conjugates Market Company Profiles
    • 27.2.1. Bayer AG
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Concortis Biotherapeutics
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. F. Hoffman-La Roche Ltd.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Immunomedics, Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Oxford BioTherapeutics
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Antibody Drug Conjugates Pipeline Analysis

29. Key Mergers And Acquisitions In The Antibody Drug Conjugates Market

30. Antibody Drug Conjugates Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer